UK markets closed

Biogen Inc. (BIIB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
222.50+1.39 (+0.63%)
As of 01:35PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close221.11
Bid222.00 x 900
Ask222.24 x 800
Day's range218.80 - 222.80
52-week range215.68 - 319.76
Avg. volume1,129,800
Market cap32.343B
Beta (5Y monthly)0.00
PE ratio (TTM)27.95
EPS (TTM)7.96
Earnings date23 Apr 2024 - 29 Apr 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est306.07
  • Insider Monkey

    20 Most Sustainable Companies in the US

    In this article, we will look into the 20 most sustainable companies in the US. If you want to skip our detailed analysis, you can go directly to the 5 Most Sustainable Companies in the US. Sustainability Outlook for the US According to the SDSN Sustainable Development Report 2023, the United States demonstrates mixed performance […]

  • Zacks

    Ionis' (IONS) Olezarsen Gets FDA's Orphan Tag for Rare Disease

    FDA grants orphan drug status to Ionis' (IONS) olezarsen for treating familial chylomicronemia syndrome (FCS). An NDA for olezarsen is expected to be filed this year.

  • Zacks

    Sage Therapeutics (SAGE) Q4 Earnings & Revenues Beat Estimates

    Sage Therapeutics' (SAGE) earnings and revenues surpass estimates in the fourth quarter of 2023. Focus on newly launched PPD drug, Zurzuvae. Stock rise.